BIOMAT Database Logo BIOMAT Database Logo

Intraperitoneal treatment of CAPD peritonitis with ciprofloxacin. 1989

H Ludlam, and I Barton
Department of Microbiology, St. Thomas' Hospital, London, UK.

UI MeSH Term Description Entries
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D003365 Costs and Cost Analysis Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs. Affordability,Analysis, Cost,Cost,Cost Analysis,Cost Comparison,Cost Measures,Cost-Minimization Analysis,Costs and Cost Analyses,Costs, Cost Analysis,Pricing,Affordabilities,Analyses, Cost,Analyses, Cost-Minimization,Analysis, Cost-Minimization,Comparison, Cost,Comparisons, Cost,Cost Analyses,Cost Comparisons,Cost Measure,Cost Minimization Analysis,Cost, Cost Analysis,Cost-Minimization Analyses,Costs,Measure, Cost,Measures, Cost
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

H Ludlam, and I Barton
Treatment of CAPD peritonitis with oral ciprofloxacin.
January 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
H Ludlam, and I Barton
Oral treatment of CAPD-peritonitis with ciprofloxacin.
January 1990, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
H Ludlam, and I Barton
Ciprofloxacin and CAPD peritonitis.
September 1990, The Journal of antimicrobial chemotherapy,
H Ludlam, and I Barton
Ciprofloxacin and CAPD peritonitis.
May 1991, The Journal of antimicrobial chemotherapy,
H Ludlam, and I Barton
Successful treatment of peritonitis in CAPD with intraperitoneal rifampin.
January 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
H Ludlam, and I Barton
Efficacy of ciprofloxacin in treatment of CAPD peritonitis.
October 1987, European journal of clinical microbiology,
H Ludlam, and I Barton
Treatment of peritonitis in CAPD with ciprofloxacin: long-term experience.
January 1993, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
H Ludlam, and I Barton
Treatment of CAPD peritonitis with intraperitoneal ampicillin/sulbactam-aminoglycoside combination.
January 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
H Ludlam, and I Barton
Intraperitoneal teicoplanin in CAPD peritonitis.
January 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
H Ludlam, and I Barton
Intraperitoneal teicoplanin in CAPD peritonitis.
January 1990, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Copied contents to your clipboard!